Anika Therapeutics (ANIK) Reports Q1 Loss, Misses Revenue Estimates

• click to rate

  Posted by Two Blokes Fri at 2:45 PM - Filed in Stock - 2 views
  
  Anika Therapeutics (ANIK) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of $0.09. This compares to loss of $0.31 per share a year ago.